Biolife Solutions (BLFS) Inventory Average (2011 - 2026)

Biolife Solutions (BLFS) has 16 years of Inventory Average data on file, last reported at $31.5 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $31.5 million, up 11.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.5 million (up 11.33% YoY), and the FY2025 annual result was $29.6 million, up 5.32% from the prior year.
• Inventory Average rose to $31.5 million in Q1 2026 per BLFS's latest filing, from $29.0 million in the prior quarter.
• Over five years, Inventory Average peaked at $41.3 million in Q3 2023 and troughed at $27.6 million in Q2 2025.
• A 5-year average of $33.2 million and a median of $32.3 million in 2024 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 151.61% in 2022, then declined 27.21% in 2025.
• A 5-year view of Inventory Average shows it stood at $34.3 million in 2022, then climbed by 2.72% to $35.3 million in 2023, then declined by 13.22% to $30.6 million in 2024, then slipped by 5.25% to $29.0 million in 2025, then climbed by 8.64% to $31.5 million in 2026.
• Business Quant data shows BLFS's Inventory Average at $31.5 million in Q1 2026, $29.0 million in Q4 2025, and $27.8 million in Q3 2025.